Literature DB >> 9224219

Doxycycline revisited.

N Joshi1, D Q Miller.   

Abstract

Although several new antibiotics have recently become available, in several clinical instances conventional antibiotics may be equally efficacious at a considerably lower cost. In today's era of cost containment, it is particularly relevant to revisit older, inexpensive antibiotics to reexplore their role in the face of the emergence of resistant microorganisms and competition from newer agents. Doxycycline is one such antibiotic. It is an inexpensive, broad-spectrum antimicrobial agent that remains the drug of first choice for several infections. In addition, it can be used for a variety of other indications. Adverse effects are infrequent and relatively minor. While interactions occur with several medications, none of these interactions has significant adverse consequences.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224219

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  24 in total

1.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

2.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

3.  In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies.

Authors:  G Marzio; K Verhoef; M Vink; B Berkhout
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

Review 4.  Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature.

Authors:  Michael O Griffin; Eduardo Fricovsky; Guillermo Ceballos; Francisco Villarreal
Journal:  Am J Physiol Cell Physiol       Date:  2010-06-30       Impact factor: 4.249

5.  Novel antibacterial nanofibrous PLLA scaffolds.

Authors:  Kai Feng; Hongli Sun; Mark A Bradley; Ellen J Dupler; William V Giannobile; Peter X Ma
Journal:  J Control Release       Date:  2010-06-04       Impact factor: 9.776

6.  Prospective Cohort Study of Single-Day Doxycycline Therapy for Mediterranean Spotted Fever.

Authors:  Elena Espejo; Marta Andrés; Maria-Consol Garcia; Anna Fajardo; Josefa Pérez; Feliu Bella
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

7.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

8.  Severe human monocytic ehrlichiosis presenting with altered mental status and seizures.

Authors:  Christian Geier; Jessica Davis; Marc Siegel
Journal:  BMJ Case Rep       Date:  2016-10-06

Review 9.  The glycylcyclines: a comparative review with the tetracyclines.

Authors:  George G Zhanel; Kristen Homenuik; Kim Nichol; Ayman Noreddin; Lavern Vercaigne; John Embil; Alfred Gin; James A Karlowsky; Daryl J Hoban
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Radical-scavenging and Pro-/anti-inflammatory Activity of Tetracycline and Related Phenolic Compounds With or Without Visible Light Irradiation.

Authors:  Yukio Murakami; Akifumi Kawata; Seiji Suzuki; Seiichiro Fujisawa
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.